Confirmed Speakers:

Thomas A. Wynn, Ph.D.,  Research and Development, Pfizer, Cambridge, MA; Immunopathogenesis Section, NIAID, NIH, Bethesda, MD   

Gerald Marti, M.D., Ph.D., FDA, Silver Spring, MD 

Oral Alpan, M.D.  Section on Immunopathogenesis,  Amerimmune, Fairfax, VA

Derya Unutmaz, M.D., The Jackson Laboratory for Genomic Medicine, Farmington, CT

David Markusic, Ph.D., University of Florida, Division of Cellular and Molecular Therapy,   Gainesville, FL

Ari Zimran, M.D., Shaare Zedek Medical Center (SZMC),    Jerusalem , Israel

Ozlem Goker-Alpan, M.D., Lysosomal and Rare Disorders Research and Treatment Center   (LDRTC), Fairfax, VA

Sarah Spiegel, Ph.D., Department of Biochemistry and Molecular Biology, VCU, Richmond, VA          

Margarita Ivanova, Ph.D., LDRTC, Fairfax, VA

Elma Aflaki, Ph.D., Molecular Neurogenetics Section, NHGRI, NIH

Gregory Grabowski, M.D., University of Cincinnati, Cincinnati, OH

Hanna Rosenbaum, M.D., Hematology and Bone Marrow Translantation, Rambam Medical Center, Haifa, Israel   

Fatima Macedo, Ph.D., Institute for Molecular and Cell Biology, Porto, Portugal

Renuka Limgala, Ph.D., LDRTC, Fairfax, VA

Anna Tylki-Szymanska, M.D., Children’s Memorial Health Institute, Warsaw, Poland

Contact: UyenSa Beese at ubeese@ldrtc.org